Skip to main content
. 2001 Sep;159(3):861–873. doi: 10.1016/S0002-9440(10)61762-2

Table 2.

Classification of Thyroid Glands According the AITD, Autoantibody Titers, Percent of Leukocyte Infiltration and Presence of Germinal Centers

Sample AITD αTq Ul/ml αTPO Ul/ml αTSHR Ul/l % LI S (N of GC)
228 GD -ve -ve 80.0 ND 1 (11)/2 (1)
255 GD -ve 25 20 ND 1 (1)
257 GD 598.0 1155.0 67.0 70.2 1 (3)
258 GD -ve -ve 118.0 ND 1 (1)
278 GD -ve -ve 16.0 ND 1 (1)
373 GD 172.1 39.2 178.0 27.7 1 (1)
378 GD 177.3 152.3 1.0 30.0 1 (1)
381 GD 162.8 48.1 ND 19.5 NO
389 GD 66.8 143.6 37.5 9.6 NO
390 GD 28.3 -ve 8.4 7.03 NO
391 GD ND 25 ND 4.9 NO
393 GD 35 42.0 62.0 43.4 1 (1)
394 GD -ve 43.5 38.0 4.8 NO
403 GD 36 550.0 -ve 38.8 2 (3)
412 GD 239 124.3 8.8 20.0 1 (4)
413 GD 37.2 39.4 20.6 5.2 NO
416 GD 56.4 40.5 -ve 9.2 NO
417 GD -ve 25 75.0 9.5 NO
423 GD 70 53 15.5 10.2 NO
424 GD -ve -ve 4.1 54.5 NO
425 GD -ve 28 4.0 11.4 NO
426 GD 1265 1001 85.9 45.4 1 (2)?
427 GD 190 1001 14.9 ND 1 (1)
429 GD -ve 7000 -ve 50 3 (2)
430 GD -ve 46 10.1 10.6 1 (1)
290 HT 584.0 766.0 -ve ND 2 (1)
384 HT ND ND ND 66.6 1 (5)
385 HT 774.0 105000 -ve 76.6 1 (1)
BL HT ND ND ND ND 1 (10)
JC HT ND ND ND ND 1 (5)
RP HT ND ND ND ND 1 (10)
AP1 HT ND ND ND ND 1 (4)
AP2 HT ND ND ND ND 1 (11)
359 MNG -ve -ve -ve 5.2 NO
360 MNG -ve -ve 2.5 1.3 NO
361 MNG -ve -ve 7 0.3 NO
362 MNG -ve -ve 1.6 6.1 NO
364* MNG -ve -ve 1.2 12.0 1 (1)
376 MNG -ve 37.9 1.4 3.5 NO
379 MNG -ve -ve 1.2 6.8 NO
395 MNG -ve -ve -ve 7.2 NO
396 MNG -ve 36 -ve 3.9 NO
399 MNG -ve 45.9 1.2 21.7 NO
409 MNG 27.5 41 -ve 20.6 NO
419 MNG 36 23 -ve 11.7 NO
420 MNG -ve -ve -ve 7.5 NO

GD, Graves disease; HT, Hashimoto thyroiditis; MNG, multinodular goitre, % LI, percentage of lymphocytic infiltration; S (N of GC), sections (number of GCs).

HHS Vulnerability Disclosure